- Report
- August 2025
- 188 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Report
- August 2025
- 195 Pages
Global
From €3156EUR$3,545USD£2,758GBP
€3507EUR$3,939USD£3,064GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €890EUR$1,000USD£778GBP
€1113EUR$1,250USD£972GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €890EUR$1,000USD£778GBP
€1113EUR$1,250USD£972GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €890EUR$1,000USD£778GBP
€1113EUR$1,250USD£972GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,245GBP
€1780EUR$2,000USD£1,556GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1068EUR$1,200USD£933GBP
€1335EUR$1,500USD£1,167GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1424EUR$1,600USD£1,245GBP
€1780EUR$2,000USD£1,556GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1068EUR$1,200USD£933GBP
€1335EUR$1,500USD£1,167GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1068EUR$1,200USD£933GBP
€1335EUR$1,500USD£1,167GBP
- Report
- April 2025
Global
From €4362EUR$4,900USD£3,811GBP
- Report
- February 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,500GBP
- Report
- August 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
- Report
- July 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- June 2025
- 150 Pages
Global
From €2403EUR$2,699USD£2,099GBP
- Report
- June 2025
- 200 Pages
Global
From €2483EUR$2,789USD£2,169GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,212USD£3,165GBP
- Report
- May 2025
- 134 Pages
Global
From €13349EUR$14,995USD£11,664GBP
- Report
- December 2024
- 59 Pages
Global
From €3556EUR$3,995USD£3,107GBP
- Report
- June 2025
Global
From €6677EUR$7,500USD£5,834GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more